0000950142-15-000742.txt : 20150414 0000950142-15-000742.hdr.sgml : 20150414 20150414201439 ACCESSION NUMBER: 0000950142-15-000742 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150414 FILED AS OF DATE: 20150414 DATE AS OF CHANGE: 20150414 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seachaid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001639140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770344 BUSINESS ADDRESS: STREET 1: 801 CAPITOLA DRIVE, SUITE 5 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-354-1800 MAIL ADDRESS: STREET 1: 801 CAPITOLA DRIVE, SUITE 5 CITY: DURHAM STATE: NC ZIP: 27713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Purcell Dennis J CENTRAL INDEX KEY: 0001297291 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770345 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 160 WEST GERMANTOWN PIKE CITY: NORRISTOWN STATE: PA ZIP: 19401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHIFF ANDREW N CENTRAL INDEX KEY: 0001172252 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770346 MAIL ADDRESS: STREET 1: PLANET ZANETT INC STREET 2: 135 E 57TH ST CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: SCHIFF DR DREW DATE OF NAME CHANGE: 20020426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AISLING CAPITAL PARTNERS LLC CENTRAL INDEX KEY: 0001376171 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770347 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: (212) 651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AISLING CAPITAL PARTNERS, LP CENTRAL INDEX KEY: 0001376172 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770348 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: (212) 651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aisling Capital II LP CENTRAL INDEX KEY: 0001350778 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 15770349 BUSINESS ADDRESS: STREET 1: 88 SEVENTH AVE 30TH FL CITY: NEW YORK STATE: NY ZIP: 10106 MAIL ADDRESS: STREET 1: 88 SEVENTH AVE 30TH FL CITY: NEW YORK STATE: NY ZIP: 10106 3 1 es1500485_3-cidara.xml OWNERSHIP DOCUMENT X0206 3 2015-04-14 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001350778 Aisling Capital II LP 888 7TH AVENUE 30TH FLOOR NEW YORK NY 10106 0 0 1 0 0001376172 AISLING CAPITAL PARTNERS, LP 888 7TH AVENUE, 30TH FLOOR NEW YORK NY 10106 0 0 1 0 0001376171 AISLING CAPITAL PARTNERS LLC 888 7TH AVENUE, 30TH FLOOR NEW YORK NY 10106 0 0 1 0 0001172252 SCHIFF ANDREW N 888 7TH AVENUE 30TH FLOOR NEW YORK NY 10106 0 0 1 0 0001297291 Purcell Dennis J 888 7TH AVENUE, 30TH FLOOR NEW YORK NY 10106 0 0 1 0 0001639140 Seachaid Pharmaceuticals, Inc. C/O AISLING CAPITAL LLC 888 7TH AVENUE, 30TH FL NEW YORK NY 10106 0 0 1 0 Common Stock 703092 I By Seachaid Pharmaceuticals, LLC. Convertible Preferred Stock 0 Common Stock 351518 I By Aisling Capital II, L.P. Shares of common stock, par value $0.0001 per share (the "Common Shares") of Cidara Therapeutics, Inc. (the "Issuer") are held directly by Seachaid Pharmaceuticals, LLC. ("Seachaid"). Shares of preferred stock, par value $0.0001 per share (the "Preferred Shares") are convertible at any time, at the holder's election, and have no expiration date. Upon the consummation of the Issuer's initial public offering, the Preferred Shares will automatically convert into Common Shares on a 25.4-to-1 basis. The Preferred Shares are directly held by Aisling Capital II, LP ("Aisling"). The investment committee of Aisling holds sole voting and dispositive power over the Common Shares held by Seachaid and the Preferred Shares held by Aisling. Aisling is a majority-owner of Seachaid. Aisling Capital Partners LP ("Aisling GP") is the general partner of Aisling and Aisling Capital Partners LLC ("Aisling Partners") is the general partner of Aisling GP. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling and Seachaid. (Cont'd in FN5) (Cont'd from FN4) Each of the Reporting Persons disclaims beneficial ownership of the Common Shares and Preferred Shares, except to the extent of such person's pecuniary interest. Mr. Elms has filed a separate Form 3 with respect to his beneficial ownership of the Common Shares and Preferred Shares. Following the closing of the Issuer's initial public offering, the Reporting Persons will no longer own more than 10% of the Issuer's Common Shares. /s/ Aisling Capital II, LP, by /s/ Lloyd Appel 2015-04-14 /s/ Aisling Capital Partners, LLC, by /s/ Lloyd Appel 2015-04-14 /s/ Aisling Capital Partners, LP, by /s/ Lloyd Appel 2015-04-14 /s/ Andrew N. Schiff 2015-04-14 /s/ Dennis J. Purcell 2015-04-14 Seachaid Pharmaceuticals, LLC, by /s/ Lloyd Appel 2015-04-14